A beneficial impact on social functioning is an important outcome of schizophrenia treatment. A recently published Japanese study is the first to demonstrate the efficacy of lurasidone compared to placebo on the social functioning of patients with schizophrenia. The results are comparable to other atypical antipsychotics.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
